Events & Training for April 2020

Pre-Filled Syringes East Coast 2021

26 April 2020 - 27 April 2020

SMi are proud to announce the 8th Pre-filled Syringes East Coast virtual conference taking place on 26th and 27th April 2021. The global pre-filled syringes market was valued at $4.9 billion in 2018 and with the rapid growth of the industry, is expected to exceed $9.7 billion by 2025. With that in mind, this event will bring together specialists within the industry to provide an exclusive insight into the sphere of regulation, new digital technology trends, human studies and innovative design and delivery systems within the prefilled syringe industry. This comprehensive overview will help attendees understand the changing global market and the challenges faced within the industry. The upcoming conference will cover key topics driving the industry including advancing development for drug delivery devices, regulatory updates including the FDA draft guidance on bridging studies, connectivity and digital health for combination products and compatibility for drug delivery systems. This two-day agenda offers you peer-to-peer networking with Global Product Managers, Senior PFS Engineers, Device Testing Managers, Heads of Late-Stage PFS Development and many more. We look forward to welcoming you to the conference in April 2021.

Virtual conference: Online access only

Pre-Filled Syringes East Coast 2020

27 April 2020 - 28 April 2020

SMi Group are proud to announce the 7th Pre-Filled Syringes East Coast conference returning to Boston, USA on 27th-28th April 2020. The global pre-filled syringes market was valued at $4.9 billion in 2018 and with the rapid growth of the industry, is expected to exceed $9.7 billion by 2025. With that in mind, for its 7th year running- the 2020 event will aim to focus on new trends on digital technology advancements, human studies and innovative design and delivery systems within the prefilled syringe industry.

Sheraton Boston Hotel, MA, USA

BioTrinity 2020

28 April 2020 - 29 April 2020

BioTrinity 2020 will now be delivered in an exciting new digital format. In this time of huge upheaval for everyone, BioTrinity Digital has been designed to provide the features of the real time conference and adds to this with additional content. Our firm belief is that it will support and generate commercial and practical value to all attendees, presenters, sponsors and the wider life sciences industry. OBN's core mission to inspire growth and create opportunities remains our priority. Embrace this digital offering and step into the future of virtual conferencing Panel Discussions and Keynotes: BioTrinity 2020 features an even better offering of Keynotes and Panel Discussions than in previous years. View the content at your leisure and make use of the additional materials on pertinent topics via the portal. BioLaunchPad Sessions: With 10-minute presentation slots BioTrinity 2020 offers an even better opportunity for companies to showcase to an audience of investors, potential collaborators and other life science players. Presentations will be available for browsing via the portal for at least 10 days to allow extended exposure. Partnering: Use the HelloPartnering meeting management system to request and accept meetings as you would normally. Then attend those meetings in our virtual partnering space. Exhibition: Take advantage of the virtual exhibition space with showcase footage, marketing collateral and company information, from our sponsor exhibitors and available to download and take away.

This meeting will now be virtual, see website for further detail

SMi’s Recombinant Chromogenic Assay as Alternate Methods for the Bacterial Endotoxins Test (BET) Webinar

29 April 2020

Recently, there has been a lot of interest associated with the potential use of synthetic (non-animal based) reagents for bacterial endotoxin testing. This webinar will provide an in-depth overview of the global perspective on the use of such reagents, including their regulatory status. This free to join webinar is sponsored by Associate of Cape Cod, the one hour webinar will focus on executing a recombinant kinetic chromogenic assay, testing samples and detailed data interpretation with the primary focus on comparability of the data with conventional amoebocyte lysate- based assays. BENEFITS FOR JOINING THE WEBINAR: This interactive webinar will provide the following benefits: - An overview of global status of recombinant reagents for BET - A session on kinetic chromogenic testing - Data interpretation - Troubleshooting kinetic chromogenic assays - Equivalency of the recombinant reagents to LAL reagents For full details and to register your free place, please visit: https://www.smi-online.co.uk/pharmaceuticals/webinar/recombinant-chromogenic-assays

WEBINAR